Novartis ٧ مايو ٢٠٢٦ Entrada's stock craters as DMD data underperform expectations, handing advantage to Novartis - Fierce Biotech
Merck & Co. ٧ مايو ٢٠٢٦ From drug development to M&A, Big Pharmas showcase AI’s ‘measurable impact’ - Fierce Biotech
Science ٧ مايو ٢٠٢٦ Short RNA chaperones promote aggregation-resistant TDP-43 conformers to mitigate neurodegeneration | Science
Science ٧ مايو ٢٠٢٦ Competitive reactivity drives size- and composition-focusing in multimetallic nanocrystals | Science
JASCO Corporation ٧ مايو ٢٠٢٦ In-Depth Examination of Segments, Industry Trends, and Key Players in the Chromatography Software Market - openPR.com
Labiotech ٧ مايو ٢٠٢٦ The rise of trispecific antibodies: Biopharma’s next big bet after bispecifics
Charles River ٧ مايو ٢٠٢٦ Charles River Laboratories (NYSE:CRL) Exceeds Q1 CY2026 Expectations - StockStory